Skip to main content
Equibles

STATE STREET CORP

Position in ATOS — Atossa Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$76,738
-$132,404 QoQ
Shares Held
39,761
0.0% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 31 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. ATOS ranks #372 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in ATOS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $76,738 39,761
2026-03-31 $209,142 39,761
2025-12-31 $351,926 596,485
2025-09-30 $395,410 454,495
2025-06-30 $428,753 516,571
2025-03-31 $1,157,150 1,727,090
2024-12-31 $1,650,046 1,755,369
2024-09-30 $2,632,975 1,732,221
2024-06-30 $1,979,018 1,663,041
2024-03-31 $888,427 493,571
2023-12-31 $383,918 436,271
2023-09-30 $322,840 436,271
2023-06-30 $549,701 436,271
2023-03-31 $346,316 480,995
2022-12-31 $254,927 480,995
2022-09-30 $399,225 480,995
2022-06-30 $524,284 480,995
2022-03-31 $2,791,262 2,233,010
2021-12-31 $3,427,280 2,142,050
2021-09-30 $6,995,803 2,145,952
2021-06-30 $12,846,461 2,032,668